Darden (NYSE: DRI) reported comparable sales for the third quarter that beat the average analyst estimate. “While we think buyside was already anticipating above-consensus 3Q results, shares are indicating higher given the magnitude of the 3Q beat, guidance for 4Q well above Street estimates, and QTD trends showing steady improvement in recent weeks,” RBC analyst Christopher Carril wrote. Price target lifted to $151. Stocks closed at $144,90 or 8,19% higher.